Search results
Results from the WOW.Com Content Network
Tramadol, sold under the brand name Ultram among others, [1] is an opioid pain medication and a serotonin–norepinephrine reuptake inhibitor (SNRI) used to treat moderately severe pain. [12] [16] When taken by mouth in an immediate-release formulation, the onset of pain relief usually begins within an hour. [12] It is also available by ...
Ambien – nonbenzodiazepine used as a sleep aid Anafranil ( clomipramine ) – a tricyclic antidepressant ; mostly used to treat OCD Antabuse ( disulfiram ) – inhibits the enzyme acetaldehyde dehydrogenase , causing acetaldehyde poisoning when ethanol is consumed; used to cause severe hangover when drinking; increases liver, kidney, and ...
Respiratory depression; Epileptiform convulsions; Involuntary muscle contractions; Abnormal coordination; Syncope (fainting) Blurred vision; Dyspnoea (shortness of breath) Tinnitus (ringing in the ears) Migraine; Stevens–Johnson syndrome/toxic epidermal necrolysis (potentially fatal skin reactions) Motorial weakness; Creatinine increase ...
Amisulpride is approved and used at low doses in the treatment of dysthymia and major depressive disorder. [10] [20] [11] [21] [22] [23] Whereas typical doses used in schizophrenia block postsynaptic dopamine D 2-like receptors and reduce dopaminergic neurotransmission, low doses of amisulpride preferentially block presynaptic dopamine D 2 and D 3 autoreceptors and thereby disinhibit dopamine ...
Many sleep studies focus on potential treatments for specific conditions. ... a potentially dangerous sleep disorder characterized by interrupted breathing during sleep, affects many people and is ...
(+)-Desmetramadol is a G-protein biased μ-opioid receptor full agonist. [4] It shows comparatively far lower affinity for the δ-and κ-opioid receptors. [5] The two enantiomers of desmetramadol show quite distinct pharmacological profiles; [6] both (+) and (−)-desmetramadol are inactive as serotonin reuptake inhibitors, [7] but (−)-desmetramadol retains activity as a norepinephrine ...
This is a list of investigational antidepressants, or drugs that are currently under development for clinical use in the treatment of depression but are not yet approved. Specific indications include major depressive disorder, treatment-resistant depression, dysthymia, bipolar depression, and postpartum depression, among others.
Agomelatine also induced an advance of the time of sleep onset and of minimum heart rate. From the first week of treatment, onset of sleep and the quality of sleep were significantly improved without daytime clumsiness as assessed by patients. [2] [11] Agomelatine appears to cause fewer sexual side effects and discontinuation effects than ...